Drug Search Results
More Filters [+]

Salinomycin

Alternative Names: salinomycin
Latest Update: 2024-05-09
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Wnt Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: Orphan Drug - Lung Cancer|Small Cell Lung Cancer *

Approval Status: Not Approved

Approved Countries: India | Malaysia | Pakistan

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Salinomycin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events